4.6 Article

Best Practices in Robot-assisted Radical Prostatectomy: Recommendations of the Pasadena Consensus Panel

Journal

EUROPEAN UROLOGY
Volume 62, Issue 3, Pages 368-381

Publisher

ELSEVIER
DOI: 10.1016/j.eururo.2012.05.057

Keywords

Consensus; Evidence-based review; Prostate; Prostate cancer; Prostatic neoplasm; Prostatectomy; Radical prostatectomy; Robotics; RARP; RALP; Robot-assisted radical prostatectomy; Robot-assisted laparoscopic radical prostatectomy

Funding

  1. Intuitive Surgical, Sunnyvale, CA, USA
  2. New England Research Institutes, Inc. (Watertown, MA, USA)

Ask authors/readers for more resources

Context: Radical retropubic prostatectomy (RRP) has long been the most common surgical technique used to treat clinically localized prostate cancer (PCa). More recently, robot-assisted radical prostatectomy (RARP) has been gaining increasing acceptance among patients and urologists, and it has become the dominant technique in the United States despite a paucity of prospective studies or randomized trials supporting its superiority over RRP. Objective: A 2-d consensus conference of 17 world leaders in prostate cancer and radical prostatectomy was organized in Pasadena, California, and at the City of Hope Cancer Center, Duarte, California, under the auspices of the European Association of Urology Robotic Urology Section to systematically review the currently available data on RARP, to critically assess current surgical techniques, and to generate best practice recommendations to guide clinicians and related medical personnel. No commercial support was obtained for the conference. Evidence acquisition: A systematic review of the literature was performed in agreement with the Preferred Reporting Items for Systematic Reviews and Meta-analysis statement. Evidence synthesis: The results of the systematic literature review were reviewed, discussed, and refined over the 2-d conference. Key recommendations were generated using a Delphi consensus approach. RARP is associated with less blood loss and transfusion rates compared with RRP, and there appear to be minimal differences between the two approaches in terms of overall postoperative complications. Positive surgical margin rates are at least equivalent with RARP, but firm conclusions about biochemical recurrence and other oncologic end points are difficult to draw because the follow-up in existing studies is relatively short and the overall experience with RARP in locally advanced PCa is still limited. RARP may offer advantages in postoperative recovery of urinary continence and erectile function, although there are methodological limitations in most studies to date and a need for well-controlled comparative outcomes studies of radical prostatectomy surgery following best practice guidelines. Surgeon experience and institutional volume of procedures strongly predict better outcomes in all relevant domains. Conclusions: Available evidence suggests that RARP is a valuable therapeutic option for clinically localized PCa. Further research is needed to clarify the actual role of RARP in patients with locally advanced disease. (C) 2012 Published by Elsevier B.V. on behalf of European Association of Urology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer

E. Lopci, G. Lughezzani, A. Castello, P. Colombo, P. Casale, A. Saita, N. M. Buffi, G. Guazzoni, A. Chiti, M. Lazzeri

Summary: In a highly-selected patient population, Ga-68-PSMA PET/CT demonstrates a higher diagnostic performance compared to PRI-MUS in the primary diagnosis of prostate cancer.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Article Urology & Nephrology

The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage

Bianca Oresta, Daniele Braga, Massimo Lazzeri, Nicola Frego, Alberto Saita, Cristina Faccani, Vittorio Fasulo, Piergiuseppe Colombo, Giorgio Guazzoni, Rodolfo Hurle, Maria Rescigno

Summary: Our study found that the urinary microbiome of male bladder cancer patients collected from catheterized urine samples is characterized by an increased abundance of Veillonella and Corynebacterium, and decreased Ruminococcus compared to controls. Different taxonomic profiles were observed in bladder washouts and midstream urines, with specific taxa showing enrichment in each sample type. These findings suggest potential diagnostic and therapeutic implications based on manipulation of the urinary microbiome.

JOURNAL OF UROLOGY (2021)

Article Oncology

Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure

Rodolfo Hurle, Roberto Contieri, Paolo Casale, Emanuela Morenghi, Alberto Saita, Nicolomaria Buffi, Giovanni Lughezzani, Piergiuseppe Colombo, Nicola Frego, Vittorio Fasulo, Marco Paciotti, Giorgio Guazzoni, Massimo Lazzeri

Summary: The study reported mid-term results of intravesical gemcitabine in non-muscle-invasive bladder cancer patients, showing a disease-free survival rate of 32.69% at 3 years. The most common adverse events were urinary symptoms and fatigue.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Urology & Nephrology

Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study

Giovanni Lughezzani, Davide Maffei, Alberto Saita, Marco Paciotti, Pietro Diana, Nicolo Maria Buffi, Piergiuseppe Colombo, Grazia Maria Elefante, Rodolfo Hurle, Massimo Lazzeri, Giorgio Guazzoni, Paolo Casale

Summary: This study aimed to evaluate the accuracy of microultrasound in diagnosing clinically significant prostate cancer, finding that microultrasound has high sensitivity but low specificity in the diagnosis of csPCa.

EUROPEAN UROLOGY FOCUS (2021)

Article Education, Scientific Disciplines

How Does Geographic Region Affect the Total and Individual Costs for Medical Students Applying to the Competitive Surgical Residencies

Adam M. Gordon, Thomas E. Ahlering

Summary: The study compared the expenses of United States medical students applying to the 5 most competitive surgical residencies by geographic region. It found that in different geographic regions, neurosurgery and plastic surgery applicants spent more on interviews, away rotations, and total costs relative to students in other specialties.

JOURNAL OF SURGICAL EDUCATION (2022)

Article Urology & Nephrology

Evidence for the integration of total and free testosterone levels in the management of prostate cancer

Linda My Huynh, Erica Huang, Maxwell Towe, Karren Liang, Farouk M. el Khatib, Faysal A. Yafi, Thomas E. Ahlering

Summary: The study found that total testosterone remained stable in men aged 40-80 years, while free testosterone decreased by 2-3% each year. Low free testosterone independently predicted high-risk prostate cancer and biochemical recurrence.

BJU INTERNATIONAL (2022)

Article Oncology

Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start

Rodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, Armando Santoro, Ottavio De Cobelli, Ettore Di Trapani, Gloria Nohales, Llorente Carlos, Ramon Duran-Merino, Massimo Lazzeri

Summary: This study evaluates the safety and efficacy of Oncofid-P-B in CIS patients who are unresponsive or intolerant to BCG, showing a 75% complete response rate after 12 weeks of treatment and a 40% complete response rate still after 15 months. Only 7 drug-related adverse events were reported, with drug concentrations below the limit of quantification in all plasma samples.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Article Urology & Nephrology

Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study

Vittorio Fasulo, Nicolo Maria Buffi, Federica Regis, Marco Paciotti, Fancesco Persico, Davide Maffei, Alessandro Uleri, Alberto Saita, Paolo Casale, Rodolfo Hurle, Massimo Lazzeri, Giorgio Guazzoni, Giovanni Lughezzani

Summary: This study evaluated the accuracy of micro-ultrasound in predicting extraprostatic extension of Prostate Cancer prior to surgery. The results showed that micro-ultrasound can accurately predict extraprostatic extension at the final pathology report in patients scheduled for robot-assisted radical prostatectomy.

WORLD JOURNAL OF UROLOGY (2022)

Article Oncology

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under Active Surveillance for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study

Vittorio Fasulo, Marco Paciotti, Massimo Lazzeri, Roberto Contieri, Paolo Casale, Alberto Saita, Giovanni Lughezzani, Pietro Diana, Nicola Frego, Pier Paolo Avolio, Piergiuseppe Colombo, Grazia Maria Elefante, Giorgio Guazzoni, Nicolo Maria Buffi, Michael Bates, Rodolfo Hurle

Summary: The study found that longitudinally repeating the Xpert BC Monitor assay can significantly reduce the number of unnecessary cystoscopies and urine cytology during follow-up.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Head-to-Head Comparison between High-Resolution Microultrasound Imaging and Multiparametric MRI in Detecting and Local Staging of Bladder Cancer: The BUS-MISS Protocol

Pietro Diana, Giovanni Lughezzani, Alberto Saita, Alessandro Uleri, Nicola Frego, Roberto Contieri, Nicolomaria Buffi, Luca Balzarini, Federico D'Orazio, Colombo Piergiuseppe, Maria Grazia Elefante, Massimo Lazzeri, Giorgio Guazzoni, Paolo Casale, Rodolfo Hurle

Summary: This study compared the diagnostic accuracy of 29-MHz high-resolution micro-ultrasound (mUS) and magnetic resonance imaging (MRI) in differentiating non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). The results showed that mUS had a better performance in distinguishing NMIBC from MIBC. However, the main limitation of mUS was its probe shape, which made its use problematic in cases with a large prostate and inadequate rectal preparation.

BLADDER CANCER (2022)

Article Surgery

External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era

Nicola Frego, Marco Paciotti, Nicolo Maria Buffi, Davide Maffei, Roberto Contieri, Pier Paolo Avolio, Vittorio Fasulo, Alessandro Uleri, Massimo Lazzeri, Rodolfo Hurle, Alberto Saita, Giorgio Ferruccio Guazzoni, Paolo Casale, Giovanni Lughezzani

Summary: In this study, the performance of the Briganti 2012 and Briganti 2019 nomograms in predicting lymph node invasion (LNI) was externally validated and compared. The results showed that the updated Briganti 2019 nomogram, which included MRI and MRI-targeted biopsy data, was not significantly more accurate than the 2012 model in predicting LNI. This suggests a negligible role of mpMRI in the current population.

FRONTIERS IN SURGERY (2022)

Article Oncology

Active Observation of Biochemical Recurrence without Treatment following Radical Prostatectomy: Long-Term Analysis of Outcomes

Erica Huang, Linda My Huynh, Joshua Tran, Adam M. Gordon, Ryan Chandhoke, Blanca Morales, Douglas Skarecky, Thomas E. Ahlering

Summary: This observational study on 407 patients with biochemical recurrence (BCR) following radical prostatectomy (RP) shows that one-third of men can be managed with active observation without the risk of prostate-related death. These findings support the idea that a significant portion of men following RP develop a benign recurrence that does not require treatment intervention.

CANCERS (2022)

Article Oncology

Prostate-Specific Antigen Doubling Time Kinetics following Radical Prostatectomy to Guide Need for Treatment Intervention: Validation of Low-Risk Recurrences

Erica Huang, Joshua Tran, Linda My Huynh, Douglas Skarecky, Robert H. Wilson, Thomas Ahlering

Summary: PSA doubling time kinetics can accurately predict the need for treatment in patients with biochemical recurrence following radical prostatectomy. One-third of the biochemical recurrences were determined to be low-risk and safely followed without treatment. This approach can prevent overtreatment and improve patient quality of life.

CANCERS (2022)

Article Oncology

Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience

Roberto Contieri, Marco Paciotti, Giovanni Lughezzani, Nicolo M. Buffi, Nicola Frego, Pietro Diana, Vittorio Fasulo, Alberto Saita, Paolo Casale, Massimo Lazzeri, Giorgio Guazzoni, Rodolfo Hurle

Summary: This study reports the long-term results and factors associated with failure in patients undergoing active surveillance for recurrent low-risk non-muscle-invasive bladder cancer. The findings suggest that well-selected patients with low-grade tumors can safely undergo active surveillance for an extended period, while multiple transurethral resections and multiple lesions at enrollment are associated with a higher risk of failure.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Urology & Nephrology

Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy

Massimo Lazzeri, Stefano Duga, Elena Azzolini, Vittorio Fasulo, Nicolo Buffi, Alberto Saita, Giovanni Lughezzani, Elvezia M. Paraboschi, Rodolfo Hurle, Alessandro Nobili, Maurizio Cecconi, Giorgio Guazzoni, Paolo Casale, Rosanna Asselta

Summary: This study compared the hospitalization rates for COVID-19 between males exposed to 5ARIs and a control group, and found that males exposed to 5ARIs had a lower risk of hospitalization. This suggests the potential protective effect of 5ARIs against severe COVID-19.

MINERVA UROLOGY AND NEPHROLOGY (2022)

No Data Available